Cencora (STU:ABG) FFO


STU:ABG Cencora Inc STU:ABG
68 GF Score
Price €251.10
GF Value €256.22
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora FFO?

FFO (Funds from operations) only applies to REITs.

STU:ABG
68GF Score
Cencora Inc STU:ABG
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cencora (STU:ABG) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be undervalued. The current stock price of €251.10 is trading 2% below its estimated GF Value™ of €256.22. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for STU:ABG:

  • FFO:
  • GF Value™: €256.22 vs. price of €251.10 (2% below fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the STU:ABG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
68GF Score

Get the complete analysis for STU:ABG

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€251.10
Price
€256.22
GF Value